EXPAREL not checked

Pacira Pharmaceuticals, Inc

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 1 trial completes
Trials
1 active
16 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Postoperative Pain
Main trialPhase 1
“This Phase 1, multicenter, open-label, randomized, bupivacaine-controlled study is designed to evaluate the pharmacokinetics (PK) and safety of EXPAREL vs. bupivacaine HCl for postsurgical analgesia in pediatric subjects aged 0 to less than 6 years of age undergoing cardiac surgery, utilizing local infiltration analgesia (LIA).”In the company’s words, NCT06271265 on ClinicalTrials.gov
Other names
Liposomal bupivacaine

Other drugs for Postoperative Pain

All 11 drugs for Postoperative Pain

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials16

TrialPhaseCompletesWhat it tests
Phase 1Recruiting Jan 2027 Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Undergoing Cardiac Surgery
Phase 4Completed May 2012 TAP-patients With Robotic Assisted Lap Prostatectomy
Phase 4Terminated Oct 2012 EXPAREL Administered Into the TAP for Analgesia in Subjects Undergoing Open Total Abdominal Hysterectomy
Phase 4Completed Dec 2012 EXPAREL Infiltrated Into the TAP for Postoperative Analgesia in Unilateral Abdominal Hernia Repair
Phase 4Terminated Dec 2013 EXPAREL Administered by Infiltration Into the TAP for Prolonged Postsurgical Analgesia in Lower Abdominal Surgeries
Phase 4Completed Apr 2015 Pharmacokinetic Evaluation of EXPAREL in Adults Undergoing Tonsillectomy
Phase 4Terminated Jun 2015 Evaluation of the Safety and Efficacy of EXPAREL When Administered Into the TAP in Subjects Undergoing Cesarean Section
Phase 4Completed 20 Nov 2018 Evaluate the Safety and Efficacy of EXPAREL When Administered Via Infiltration Into the TAP vs. Bupivacaine Alone in Subjects Undergoing Elective C-Sections
Phase 3Completed Jun 2013 Intercostal Nerve Block With Liposome Bupivacaine in Subjects Undergoing Posterolateral Thoracotomy
Phase 3Completed 30 Aug 2019 Multicenter Study for Pediatric Subjects Evaluating Pharmacokinetics and Safety of EXPAREL
Phase 3Completed 5 Apr 2021 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of EXPAREL, EXPAREL Admixed With Bupivacaine HCl vs. Bupivacaine HCl Administered as Combined Sciatic and Saphenous Nerve Blocks for Postsurgical Analgesia in Subjects Undergoing Lower Extremity Surgeries
Phase 1Completed Sep 2014 Safety and Pharmacokinetics Study of Redosing EXPAREL in Healthy Volunteers
Phase 1Completed 12 Feb 2019 Study in Pediatric Subjects Evaluating Pharmacokinetics and Safety of EXPAREL
Phase 1Completed 2 Dec 2019 Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety, of EXPAREL Administered as Sciatic Nerve Block (In Popliteal Fossa), for Postsurgical Analgesia in Subjects Undergoing Bunionectomy
Phase 1Completed 15 Jan 2020 Study to Evaluate the Pharmacokinetics and Safety of EXPAREL Administered as a Pectoral Plane Block in Women Undergoing Breast Augmentation
Phase 1Terminated 7 Dec 2020 Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of EXPAREL® Administered Via a Single Intrathecal Injection to Healthy Volunteers
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow EXPAREL

Following is part of Solo: you see every change to EXPAREL the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in